Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 39OTHER 13NIH 6OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 19Magnetic Resonance Spectroscopy 15Dexamethasone 9Vincristine 7Radiation 7Cyclophosphamide 7daratumumab 6Radiotherapy 6Leucovorin 6Lenalidomide 6Cisplatin 6Calcium Dobesilate 6durvalumab 5dexamethasone acetate 5dexamethasone 21-phosphate 5auricularum 5Standard of Care 5Radiotherapy, Conformal 5Radiosurgery 5Practice Guidelines as Topic 5Gemcitabine 5Doxorubicin 5Bortezomib 5Radiotherapy, Intensity-Modulated 4Paclitaxel 4Fluorouracil 4Etoposide 4Biopsy 4X-Rays 3Taxes 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × 130-nm albumin-bound paclitaxel × 30 days × Clear all
NCT06998940 2026-05-22

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

SWOG Cancer Research Network

Phase 3 Recruiting
94 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡